Found 5 matching trials
Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin
PHASE3This clinical study aims to evaluate the efficacy and safety of the anticoa...
Location
Bryansk City Hospital No. 1
Dimolegin® (60 mg) for Patients With Moderate COVID-19: A Non-Interventional Study
N/AA multicenter, open-label, non-interventional study evaluates the safety an...
Location
Regional Clinical Hospital No. 3
A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement
PHASE2This study is a multicenter, double-blind, randomized, prospective phase 2 ...
Location
GAUZ Bryansk City Hospital No. 1
Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19
PHASE3Study purpose was to study the safety and efficacy of Dimolegin - DD217 as ...
Location
Regional budgetary healthcare institution Ivanovskaya clinical hospital named after Kuvaevs
A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)
PHASE1In the course of the clinical study, the pharmacokinetics, pharmacodynamics...
Location
Non-Governmental Private Healthcare Institution of Sci-entific Clinical Center of Russian Railways JSC